XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating Expenses:        
Research and development $ 9,098 $ 4,894 $ 15,616 $ 9,324
General and administrative 3,115 1,090 6,010 2,243
Total operating expenses 12,213 5,984 21,626 11,567
Loss from operations (12,213) (5,984) (21,626) (11,567)
Other income (expense):        
Grant income 6,385 4,646 12,289 9,338
Change in the fair value of the derivative liability   1,146   2,209
Change in the fair value of the Simple Agreements for Future Equity   (1,044)   (1,044)
Other (expense) income, net (42) 103 (237) 248
Gain on debt extinguishment       443
Interest expense, net (7) (357) (16) (894)
Total other income, net 6,336 4,494 12,036 10,300
Loss before income tax (5,877) (1,490) (9,590) (1,267)
Income tax benefit 125      
Net (loss) income (5,752) (1,490) (9,590) (1,267)
Cumulative preferred stock dividends   (1,339)   (2,467)
Net loss attributable to common stockholders (5,752) (2,829) (9,590) (3,734)
Unrealized gain (loss) on foreign currency translation (3) (1) (2) (6)
Total comprehensive (loss) income $ (5,755) $ (1,491) $ (9,592) $ (1,273)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.25) $ (4.77) $ (0.43) $ (6.53)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.25) $ (4.77) $ (0.43) $ (6.53)
Weighted-average common shares outstanding, basic (in shares) 22,595,359 593,431 22,511,636 571,921
Weighted-average common shares outstanding, diluted (in shares) 22,595,359 593,431 22,511,636 571,921